Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000950170-25-023166

Chief Legal Officer sold 10,000 shares at $34.00 ($340,000)

  • Chief Legal Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bellon Christine Chief Legal Officer 2025-02-14 Option exercise 10b5-1 +9,492 $7.22 $68,532 112,460 D
Bellon Christine Chief Legal Officer 2025-02-14 Option exercise 10b5-1 +508 $7.22 $3,668 112,968 D
Bellon Christine Chief Legal Officer 2025-02-14 Sale 10b5-1 −10,000 $34.00 $340,000 102,968 D
Derivatives
Bellon Christine Chief Legal Officer 2025-02-14 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,492 0 D
Bellon Christine Chief Legal Officer 2025-02-14 Option exercise · Stock Option (Right to Buy) 10b5-1 −508 10,410 D
Open-market sales · 10,000 sh · avg $34.00 · $340,000
Loading xslF345X05/ownership.xml…